PCDHB14 and hepatocellular carcinoma: For instance, protocadherin beta 14 (CDHB14), is downregulated in HCC patients, represses cell proliferation by promoting ferroptosis via the blockage of p65/SLC7A11interaction, suggesting a tumor-suppressing role of CDHB14 in HCC (Liu et al., 2022).